Thursday February 16, 2006
Join the show: 1-800-433-8850 (drshow@wamu.org) or contact us
Week of February 13, 2006
Your Amazon.com purchases support WAMU 88.5
Your purchases from the NPR Store support WAMU 88.5
A scientific advisory panel voted 8 to 7 to recommend that the strongest possible safety warning be added to the labeling for certain drugs used to treat attention-deficit/hyperactivity disorder. A panel talks about what's behind this recommendation and how these drugs are being used and abused.
Dr. Steven Nissen, cardiologist at the Cleveland Clinic and a member of the FDA advisory panel that voted to recommend the strongest possible safety warning on certain drugs used to treat AD/HD
Dr. Jay Salpekar, director of outpatient psychiatry services at Children's National Medical Center
Dr. Lawrence H. Diller, behavioral developmental pediatrician practicing in Walnut Creek, Ca. and a member of the clinical faculty at the University of California--San Francisco. Author of "Running on Ritalin."
Lew Mills, psychotherapist in private practice in San Francisco who is taking medication for AD/HD, as are his two children
A look at how the world's largest retailer is transforming the American economy.
Charles Fishman, senior writer, Fast Company
privacy policy - terms of use - contact - sitemap - directions - rss - podcasts - jobs
Copyright WAMU 88.5 American University Radio | 4000 Brandywine Street NW | Washington, DC 20016-8082 | (202)885-1200
